Nicole Blijlevens
Corporate Officer/Principal presso GLyPharma Therapeutic, Inc.
Provenienza dei contatti di primo grado di Nicole Blijlevens
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
GLyPharma Therapeutic, Inc.
 GLyPharma Therapeutic, Inc. BiotechnologyHealth Technology GLyPharma Therapeutic, Inc. develops oncology therapeutic treatment. It engages in the development of the clinical efficacy of FE 203799, a novel proprietary Glucagon-Like Peptide-2(GLP-2) analogue exerting unique pharmacological effects in a first-in-class, meaningful indication for patients with hematological malignancies receiving myelotoxic therapies. The company was founded in August 2012 and is headquartered in Montreal, Canada.
7
| Subsidiary | Biotechnology | 7 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Nicole Blijlevens tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| DOW CHEMICAL COMPANY (THE) | Chemicals: Specialty | Corporate Officer/Principal | |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chairman | |
Shionogi Pharma, Inc.
 Shionogi Pharma, Inc. Pharmaceuticals: MajorHealth Technology Shionogi Pharma, Inc. manufactures pharmaceuticals. The company is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Chairman | |
| AETERNA ZENTARIS INC. | Pharmaceuticals: Major | Director/Board Member | |
Bioxel Pharma, Inc.
 Bioxel Pharma, Inc. BiotechnologyHealth Technology Bioxel Pharma, Inc. develops pharmaceutical products used in the treatment of cancer, multiple sclerosis and Alzheimers. The company is engaged in the development, production and distribution of therapeutically active taxanes isolated from the Canadian yew. Bioxel Pharma was founded on July 13, 1995 and is headquartered in Quebec, Canada. | Biotechnology | Chairman | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GELESIS INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Arteaus Therapeutics LLC
 Arteaus Therapeutics LLC BiotechnologyHealth Technology Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | President | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
Business Development Bank of Canada
 Business Development Bank of Canada Finance/Rental/LeasingFinance Business Development Bank of Canada provides commercial banking services. It offers business loans and consulting services to help Canadian businesses grow, both at home and abroad. The firm also offers a full spectrum of specialized financing, including venture capital, equity as well as growth and business transition capital through its subsidiaries. The company was founded in 1995 and is headquartered in Montreal, Canada. | Finance/Rental/Leasing | Corporate Officer/Principal | |
CTI Capital, Inc.
 CTI Capital, Inc. Investment ManagersFinance CTI Capital, Inc. is a Venture Capital firm, a subsidiary of CTI Capital Groupe, Inc. founded in 1987. CTI Capital, Inc. is headquartered in Montréal. | Investment Managers | Private Equity Investor Private Equity Investor | |
Benelux Real Estate AG
 Benelux Real Estate AG Real Estate DevelopmentFinance Part of AGIV Real Estate AG, Benelux Real Estate AG engages in real estate development. | Real Estate Development | Corporate Officer/Principal | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member | |
| Xavier University | College/University | Undergraduate Degree | |
Fonds de Solidarité FTQ
 Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Investment Managers | Private Equity Investor | |
| University of Montréal | College/University | Undergraduate Degree Corporate Officer/Principal | |
Limulus Management Co. LLC
 Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co. LLC is a venture capital firm founded by Lawrence Miller and Paul Howard in 1999. It is headquartered in Newton, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| HEC Montréal | College/University | Undergraduate Degree | |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Corporate Officer/Principal | |
Montréal International
 Montréal International Miscellaneous Commercial ServicesCommercial Services Montréal International attracts and promotes economic development of Greater Montreal. The company was founded in 1996 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Algorithme Pharma, Inc.
 Algorithme Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Algorithme Pharma, Inc. engages in the provision of cal research services. The company was founded by Louis Caillé in 1992 and is headquartered in Laval, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member | |
| Hoechst Marion Roussel, Inc. | President | ||
| Canada's Research Based Pharmaceutical Cos. | Director/Board Member | ||
| North America Ethypharm, Inc. | Chief Executive Officer | ||
| Rhone-Poulenc Canada, Inc. | President | ||
| Pharmaceutical Manufacturers Association of Canada | Director/Board Member | ||
| Harvard Medical School | College/University | Doctorate Degree | |
| Rhone-Poulenc Pharmaceuticals, Inc. | Chairman | ||
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Founder | |
| MEDEXUS PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman | |
K2 Biotechnology Ventures LLC
 K2 Biotechnology Ventures LLC Miscellaneous Commercial ServicesCommercial Services K2 Biotechnology Ventures LLC engages in accelerating the commercialization of university, medical center, and healthcare innovations. The private company is based in Chicago, IL. The company was founded by Kenneth B. Kashkin, Jane E. Kiernan. | Miscellaneous Commercial Services | Director/Board Member | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 31 |
| Canada | 18 |
| Francia | 2 |
| Germania | 2 |
Settori
| Health Technology | 23 |
| Finance | 10 |
| Commercial Services | 7 |
| Consumer Services | 6 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 29 |
| Corporate Officer/Principal | 13 |
| Chief Executive Officer | 7 |
| President | 7 |
| Chairman | 7 |
Contatti più connessi
| Insiders | |
|---|---|
| Pierre LaPalme | 21 |
| Thomas Schuetz | 17 |
| Jean-Francois Leprince | 11 |
| Ken Pastor | 6 |
| Michael Seckler | 6 |
| Gaétan Gravel | 6 |
| Aleksandr Lazaryan | 1 |
- Borsa valori
- Insiders
- Nicole Blijlevens
- Connessioni Società
